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Oxytocin (Sintocynon) is considered an uncommon cause of severe allergic reactions during delivery. We have recently
shown that allergic sensitization to latex might constitute an important predisposing risk factor for anaphylaxis after the
first infusion of oxytocin during delivery.
Some oxytocin cardiovascular activities such as lowering blood pressure, negative cardiac inotropy and cronotropy,
parasympathetic neuromodulation, vasodilatation etc. can induce significant side effects mimicking cardiac anaphylaxis,
and constitute an additional differential diagnostic problem in delivering women with suspected or real allergic
background. Finally, some ex vivo models have shown that oxytocin, under pro-inflammatory cytokines stimulation,
such as those occurring in asthma, may induce contraction of smooth muscle and airway narrowing.
This background suggests that allergic sensitization to latex allergens constitutes a significant but underestimated risk
factor for triggering severe systemic reactions after the infusion of oxytocin and, consequently, there is a need of
particular attention in managing delivering women suffering from latex allergy and bronchial asthma. An accurate
anamnestic, clinical and diagnostic evaluation, latex-free anesthesiological setting, use of oxytocin-alternative agents
and, if necessary, a drug premedication are likely to reduce the risk of anaphylactic/broncho-obstructive reactions in
these women.
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Oxytocin (Sintocynon) is usually considered an uncom-
mon cause of severe allergic reactions during delivery.
Very few documented reports on anaphylactic/anaphy-
lactoid reactions as well as severe airway obstruction
have been published [1-6]. However, some experimental
data highlight the possibility that the risk of developing
severe systemic reactions after the infusion of oxytocin
during delivery could be higher than expected in some
allergic women. In this context, allergic sensitization to
latex, the second most frequently incriminated substance
inducing anaphylaxis during anesthesia [7], which is also
a relatively common condition in female sex [8], might* Correspondence: gennaro.liccardi@tin.it
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reproduction in any medium, provided the orrepresent an important predisposing risk factor. It is im-
portant to outline that hypersensitivity reactions in
anesthesia setting are significantly higher in adult
women than in men [9]; moreover, Draisci et al. [10]
reported a higher prevalence of latex sensitization in the
obstetric population than in non-pregnant subjects
undergoing gynaecologic surgery.
Ogata and Minami [11] demonstrated homology in the
protein sequence of oxytocin and latex allergens Hev b
7.01 and Hev b 7.02 (patatin). These authors suggested
that, in their patient sensitized to patatin, subsequent ad-
ministration of oxytocin could facilitate the antigen recog-
nition, resulting in an anaphylactic response to latex.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.mrmjournal.com/content/8/1/67We have recently described two life-threatening anaphyl-
actic reactions with onset a few minutes after the infusion
of oxytocin in two women sensitized to latex allergens [12].
Both reactions occurred during caesarian section under
spinal anaesthesia in the delivery room of our Hospital.
Diagnostic procedures confirmed an IgE - mediated al-
lergic response to both latex and oxytocin, no allergic re-
sponse was found to other agents used before or during
caesarian section such as local antiseptics, proton-pump
inhibitors, antihypertensive drugs, low molecular weight
heparin (enoxaparin sodium), human albumin.
In view of the few data available in literature, we be-
lieve that this topic is underestimated because such ad-
verse events might be easily attributed to latex allergy or
to usual “side effects” or alternative/unknown causes.
Moreover, this risk could be underestimated if we con-
sider that female sex shows higher prevalence of both
hypersensitivity reactions in the anesthesia setting and
latex allergy than men.
Among the possible “side effects”, it is important to out-
line the role of oxytocin on heart [13].
It has been shown that both oxytocin and its receptors
are found in the heart and large vessels [14], where accu-
mulating evidence demonstrates cardio protective effects
such as natriuresis, altered insulin liberation and anti-
diabetic actions, antioxidant actions, inhibition of inflam-
mation, stimulation of endothelial markers in mesenchy-
mal cells and stem cells [15-18].
However, several other cardiovascular activities such as
lowering blood pressure, negative cardiac inotropy and
cronotropy, parasympathetic neuromodulation, vasodilata-
tion etc. which may be beneficial in some clinical condi-
tions, can induce significant side effects during deliveryCARDIO- PROTECTIVE  EFFECTS  OF
Natriuresis
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Figure 1 Cardio protection and anaphylactic-like effects of oxytocin.[13]. These side effects mimicking cardiac anaphylaxis rep-
resent an additional differential diagnostic problem in deliv-
ering women with suspected or real allergic background
[19] (Figure 1). In this context it is important to outline the
necessity of serum tryptase determination to confirm the
diagnosis of anaphylaxis.
Oxytocin induces uterine contractions during delivery
and milk ejection during lactation through activation of
a specific G protein-coupled receptor [20]. The expres-
sion of this receptor increases before the onset of labour
highlighting uterine muscle sensitivity and promoting
myometrial shortening.
Interestingly, it has been shown that the expression of
oxytocin receptors plays a role not only in uterine but
also in other human tissues such as kidney, ovary, heart,
vascular endothelium etc. Labour and inflammation in-
crease the expression of oxytocin receptors in human
amnion [21], inflammatory conditions may also increase
the production of oxytocin receptors in cultivated pri-
mary uterine smooth muscle cells [22].
Recently oxytocin receptors have been found also in
human airway smooth muscle [23]. Moreover, Amrani
et al. [24] have shown that asthma-related cytokines (IL-
13 and TNF alpha) modulate the expression of oxytocin
receptors in human airway smooth muscle function
suggesting a potential role of inflammation-induced
changes in oxytocin receptor signaling in the regulation of
airway hyper-responsiveness in asthma. In other words, in
this ex vivo model, oxytocin, under pro-inflammatory cy-
tokines stimulation, may induce contraction of smooth
muscle and airway narrowing suggesting that oxytocin
serves as a bronchoconstrictor [24]. As a confirmation of
this possibility, a case of exclusive severe airway  OXYTOCIN
l and  stem cells
g women with allergic background 
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http://www.mrmjournal.com/content/8/1/67involvement (bronchospasm and laryngeal stridor) after
oxytocin administration has also been reported [25].
Taken together, these data suggest that inflammatory
conditions of airways such as those found in asthmatic
women might constitute an independent (from anaphyl-
axis) risk factor for airway obstruction after infusion of
oxytocin during delivery. The role of oxytocin receptors
could also explain the well known worsening of asthma
control in about one-third of pregnant women suffering
from asthma [26-28].
Finally, Gonzalez-Perez et al. have shown that women
suffering from severe asthma are at higher risk of ana-
phylaxis than men [29], as a consequence the risk of de-
veloping anaphylaxis, asthma exacerbation or both is
likely high in severe asthmatic women (Figure 2).
Since oxytocin causes the alveoli in the breasts to con-
tract causing milk let-down as the milk ejection reflex,
there is some controversy over whether or not a woman
can be “allergic to breastfeeding”. In fact there are
women who have allergy-like symptoms associated with
the milk ejection reflex during breastfeeding. These
symptoms can include itching, redness, rash or hives on
the trunk, arms or legs, anaphylactic reactions as they
have been also shown [30]. It has been suggested that
these symptoms can also represent adverse reactions to
the synthetic forms of oxytocin. Systemic reactions to
preservatives contained in preparations of oxytocin has
been also described [31].
Although in vivo tests with oxytocin have not been stan-
dardized, a diluted/undiluted oxytocin solution should beAnaphylaxis
Sensitization to 
Latex  
- Accurate pre-delivery allergy evaluation (e.g. 
latex, latex cross-reacting fruits etc.)
- Use of latex- free surgical materials
- Use of Oxytocin-alternative agents




Figure 2 Suggested correlation between latex, oxytocin sensitizationused by skin prick test/intradermal test. In our case report,
both patients reacted after the use of skin prick test and,
consequently, intradermal test was not necessary [12].
Latex hypersensitivity should be excluded by using
in vivo (skin prick tests) and in vitro (evaluation of spe-
cific IgE antibodies by classic or, if possible, micro-array
technique) tests.
Conclusions
In conclusion, our findings suggest a particular attention
in managing delivering women suffering from latex allergy
and bronchial asthma. An accurate anamnestic, clinical
and diagnostic evaluation, latex-free anesthesiological set-
ting, use of oxytocin-alternative agents and, if suffering
from asthma, a drug premedication [32] are likely to re-
duce the risk of anaphylactic or airway-obstructive reac-
tions in these women.
Further in vitro studies are necessary to establish the
occurrence of an immunological cross-reaction be-
tween latex and oxytocin as well as the role of oxytocin
and its receptors in heart and airway. Finally, further
clinical studies should be designed to a better under-
standing/management of respiratory and cardiac effects
of oxytocin administration.Summary statement
Oxytocin may constitute a risk factor for anaphylaxis,





- Pre- delivery evaluation of asthma 
control and, if necessary,  integration with 
usual anti- asthma  drugs (30)
- In the case of poor or non-controlled 
asthma, a drug supplementation just 
before delivery could be necessary (30)
 to 
 
and airway inflammatory conditions.
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